Latest Breaking News On - Huons global - Page 4 : comparemela.com

Prestige Biopharma s New Vaccine Production Centre for Infectious Diseases Including COVID-19

Press release content from Business Wire. The AP news staff was not involved in its creation. Prestige Biopharma’s New Vaccine Production Centre for Infectious Diseases Including COVID-19 April 20, 2021 GMT New Prestige BioPharma vaccine centre in South Korea (Photo: Business Wire) SINGAPORE (BUSINESS WIRE) Apr 20, 2021 Prestige Biopharma Limited (PBP), specializing in the development of antibody therapeutics, announces that the company will be introducing a vaccine development and production centre into its core business. PBP has been preparing for a business expansion into the development of vaccine-based therapeutics since the start of the ongoing COVID-19 outbreak as a response to the current, and potential future, viral pandemics. The design, development and implementation of the vaccine centre has resulted from that plan.

Kyongsang buktoSouth koreaYujin suhPrestige biopharma limitedPrestige biopharmaPrestige biopharma ltdGlobal communication teamBiopharma limitedBusiness wirePrestige biologicHuons globalDrug substanceதெற்கு கொரியாஉலகளாவிய தொடர்பு அணிவணிக கம்பிப்ரெஸ்டீஜ் உயிரியல்

South Korean Company to Begin Producing Russia s Sputnik V in May, Reports Say

South Korean Company to Begin Producing Russia s Sputnik V in May, Reports Say
sputniknews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sputniknews.com Daily Mail and Mail on Sunday newspapers.

South koreaHankook korusRussian direct investment fundHuons globalதெற்கு கொரியாரஷ்ய நேரடி முதலீடு நிதி

COVID-19 vaccine: South Korean consortium to produce 100 million Sputnik V doses

COVID-19 vaccine: South Korean consortium to produce 100 million Sputnik V doses The announcement comes after South Korean biotech firm GL Rapha signed a deal with Russia s sovereign wealth fund late last year to make more than 150 million doses of Sputnik V per year Reuters | April 16, 2021 | Updated 09:17 IST South Korea s Huons Global Co Ltd (084110.KQ) said on Friday it will lead a consortium to produce 100 million doses of Russia s Sputnik V COVID-19 vaccine per month as Moscow ramps up production for supplies abroad. The announcement comes after South Korean biotech firm GL Rapha signed a deal with Russia s sovereign wealth fund late last year to make more than 150 million doses of Sputnik V per year.

South koreaSouth koreanBoran pharmaEuropean medicines agencyKorea huons global co ltdRussian direct investment fundHuons global co ltdHuons globalதெற்கு கொரியாதெற்கு கொரியன்ரஷ்ய நேரடி முதலீடு நிதி

Korean consortium to produce Russia s Sputnik V vaccine for export

Korean consortium to produce Russia s Sputnik V vaccine for export Posted : 2021-04-16 11:08 Huons Global s factory in Jecheon, North Chungcheong Province / Courtesy of Huons Global South Korean biotech company Huons Global said Friday that it has signed a technology transfer deal with Russia s sovereign wealth fund to produce a Russian COVID-19 vaccine in South Korea. Under the agreement with the Russian Direct Investment Fund, the Huons Global-led consortium will manufacture Sputnik V in South Korea. Three other participants in the consortium are two South Korean companies ― Humedix and Boran Pharma ― and Singapore s Prestige BioPharma. Huons Global said it is set to begin pilot production of the Russian vaccine in August at the consortium s facilities with a monthly maximum production capacity of 100 million doses, an amount that could nearly cover South Korea s 52 million population.

United arab emiratesCh ungch ong buktoSouth koreaBuenos airesDistrito federalSouth koreanSouth koreansBoran pharmaVilla martelliPrevention agencyNational research centre for epidemiologyRussian direct investment fundHuons globalNorth chungcheong provinceHuons global ledTecnopolis park

SKorean consortium to produce 100 million doses of Russian vaccine per month

SKorean consortium to produce 100 million doses of Russian vaccine per month Photo: Reuters Reuters, Seoul Reuters, Seoul South Korea s Huons Global said on Friday (Apr 16) that it will lead a consortium to produce 100 million doses of Russia s Sputnik V Covid-19 vaccine per month as Moscow ramps up production for supplies abroad. The announcement comes after South Korean biotech firm GL Rapha signed a deal with Russia s sovereign wealth fund late last year to make more than 150 million doses of Sputnik V per year. Huons said the consortium will begin producing sample batches in August and respond flexibly to supply demands from the Russian Direct Investment Fund (RDIF).

South koreaSouth koreanBoran pharmaEuropean medicines agencyRussian direct investment fundHuons globalதெற்கு கொரியாதெற்கு கொரியன்ரஷ்ய நேரடி முதலீடு நிதி